Alsubhi, N. (2018). Targeting ataxia telangiectasia-mutated and Rad3-related kinase (ATR) in PTEN-deficient breast cancers for personalized cancer therapy.
Chicago Style (17th ed.) CitationAlsubhi, Nouf. Targeting Ataxia Telangiectasia-mutated and Rad3-related Kinase (ATR) in PTEN-deficient Breast Cancers for Personalized Cancer Therapy. 2018.
MLA (9th ed.) CitationAlsubhi, Nouf. Targeting Ataxia Telangiectasia-mutated and Rad3-related Kinase (ATR) in PTEN-deficient Breast Cancers for Personalized Cancer Therapy. 2018.
Warning: These citations may not always be 100% accurate.